Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- DKK | -.--% | -.--% | -0,50% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01/03/16 |
Chief Tech/Sci/R&D Officer | - | 13/09/17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01/03/16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01/04/16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01/01/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The private company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
-0,50% | 1,64 Md | |
+5,31% | 70,44 Md | |
+10,97% | 8,94 Md | |
-16,83% | 4,75 Md | |
+43,48% | 4,5 Md | |
+3,20% | 3,85 Md | |
+18,82% | 2,38 Md | |
-21,36% | 2,34 Md | |
-29,67% | 2,2 Md | |
+8,38% | 1,96 Md |
- Bourse
- Actions
- Action VELO
- Société Veloxis Pharmaceuticals A/S